Experts Warns Of Need For Malaria Drug Therapy

As malaria is a life threatening disease causing by the mosquitoes which is as knowing as the mosquito-borne blood disease. The Anopheles mosquito transmitting it to humans. But by this malaria expert giving warnings of the need for malaria drug to treat severe cases in US region. Each year there are more than 200 million cases of malaria worldwide; a mosquito-borne disease caused by a parasite that brings on fever and body aches and, in some cases; more serious conditions such as coma and death.

The parasites in mosquitoes that spreading malaria belong to the Plasmodium genus; While the vast majority of these cases occur in sub-Saharan Africa and South Asia, the U.S. each year sees more than 1,500 cases; and currently there is limiting access to an intravenously-administering (IV) drug needing for the more serious cases.

Need for malaria drug

Treatment for severe malaria cases is an intravenous administering (IV) form of quinidine gluconate. However, there is no longer a widely available supply of this drug in IV form in the United States. Severe malaria is a medical emergency that requires immediate treatment with IV medication to reduce the risk of death

But in a pediatric infectious diseases specialist and malaria expert in UMSOM’s Malaria Research Program within the CVD. Centers for Disease Control and Prevention (CDC) statistics showing more than 1,500 malaria cases in the U.S., of which 259 were serious and needed IV treatment. Now, with increased global inter connectedness, the rate of U.S. malaria cases is indeed rising steadily over the past 40 years, according to the CDC.

Food and drug administration

Since 1991, quinidine has been the only Food and Drug Administration approved (FDA) treatment for severe malaria. However, since April of 2019, remaining supplies of IV administered quinidine have expired, leaving U.S. physicians with no readily available treatment. Without a broad supply of the IV drug, physicians treating serious malaria cases must on a case by case basis request IV artesunate, a non-FDA approved drug for severe malaria that is only available from the CDC at ten different airports in the U.S.

The CDC will then ship the drug to the airport closest to a requesting hospital. Delivery times will take on average eight hours, but they could be as long as 24 hours. Malaria is a leading killer worldwide, impacting millions of people each year. While we continue to work on developing vaccines and other treatments, it is critical that patients everywhere have access to the regimens needed to combat this disease